NumerixS Investment Technologies’s Vertex Pharmaceuticals VRTX Stock Holding History

NumerixS Investment Technologies’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-300	Closed	-$87K	–	832
2020 Q2	$87K	Buy	+300	New	+$81.3K	0.02%	626
2020 Q1	–	Sell	-7,500	Closed	-$1.64M	–	1298
2019 Q4	$1.64M	Buy	7,500 +7,000	+1,400%	+$1.42M	0.32%	61
2019 Q3	$85K	Sell	500 -553	-53%	-$97.8K	0.02%	598
2019 Q2	$193K	Sell	1,053 -2,547	-71%	-$445K	0.06%	419
2019 Q1	$656K	Buy	3,600 +3,500	+3,500%	+$646K	0.09%	285
2018 Q4	$16K	Sell	100 -5,898	-98%	-$1.02M	0.01%	950
2018 Q3	$1.14M	Buy	5,998 +398	+7%	+$70.9K	0.21%	132
2018 Q2	$827K	Buy	5,600 +3,500	+167%	+$543K	0.19%	145
2018 Q1	$335K	Buy	+2,100	New	+$343K	0.08%	274
2017 Q4	–	Sell	-2,600	Closed	-$395K	–	1374
2017 Q3	$395K	Sell	2,600 -5,300	-67%	-$798K	0.09%	298
2017 Q2	$1.02M	Buy	+7,900	New	+$951K	0.15%	165
2016 Q2	–	Sell	-9,000	Closed	-$715K	–	1255
2016 Q1	$715K	Buy	+9,000	New	+$814K	0.08%	340

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NumerixS Investment Technologies's VRTX Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Vertex Pharmaceuticals (VRTX) in Q3 2020, closing a stake of 300 shares — an estimated $87K sold.

NumerixS Investment Technologies first reported a position in VRTX in Q1 2016 and held it in 12 quarters. The position peaked at $1.64M in Q4 2019. 950 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

NumerixS Investment Technologies reported no remaining Vertex Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 300 Vertex Pharmaceuticals shares in Q3 2020, an estimated $87K.
NumerixS Investment Technologies first reported a position in Vertex Pharmaceuticals in Q1 2016 and held it in 12 quarters.
NumerixS Investment Technologies's Vertex Pharmaceuticals position peaked at $1.64M in Q4 2019.
950 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.